|
Novel Approach to Enhance Cord Blood-Mediated Bone Marrow Homing and Engraftment
|
1R43CA139602-01
|
$193,658
|
$193,658
|
MILLER, LEONARD
|
AMERICAN STEM CELL, INC.
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$233,615
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
5R03CA130725-02
|
$84,500
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
1R21CA123855-01A2
|
$391,915
|
$391,915
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
7R01CA113969-04
|
$316,480
|
$158,240
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Enhancing Activity of Alkylating Agents in Neuroblastoma
|
5R01CA082830-07
|
$210,659
|
$69,517
|
REYNOLDS, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
$155,809
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-02
|
$289,644
|
$289,644
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CCNY/MSK Cancer Center Partnership, Training and Community Outreach
|
1U54CA132378-01A1
|
$1,622,324
|
$275,795
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
3R01CA077544-10S1
|
$110,460
|
$110,460
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
5R01CA077544-10
|
$468,767
|
$468,767
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$538,769
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$21,881
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$24,705
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-26S1
|
$86,513
|
$86,513
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-26
|
$2,908,648
|
$2,908,648
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-03
|
$416,424
|
$416,424
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Host-Tumor Cell Interactions in Myeloma:
|
3P01CA078378-10S1
|
$1,346,410
|
$444,315
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$349,253
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Rebuilding Immunity for Survival
|
5U19CA100265-05
|
$2,757,436
|
$2,757,436
|
NADLER, LEE
|
DANA-FARBER CANCER INSTITUTE
|
|
GM-CSF secreting tumor cell vaccines to enhance post-transplant anti-CLL immunity
|
1R21CA132232-01
|
$378,360
|
$189,180
|
WU, CATHERINE
|
DANA-FARBER CANCER INSTITUTE
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S1
|
$40,000
|
$400
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S2
|
|
$0
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S3
|
$249,999
|
$2,500
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S4
|
$85,106
|
$851
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S5
|
$100,000
|
$1,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-34
|
$6,558,287
|
$65,583
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
|
5R01CA132110-02
|
$300,960
|
$300,960
|
Szabolcs, Paul
|
DUKE UNIVERSITY
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-11
|
$310,291
|
$31,029
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
Family Decision Making in Pediatric Bone Marrow Transplant
|
1R21CA131875-01A1
|
$232,705
|
$232,705
|
PENTZ, REBECCA
|
EMORY UNIVERSITY
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
1R43CA134172-01
|
$112,978
|
$56,489
|
Houghton, Michael
|
EPIPHANY BIOSCIENCES, INC.
|
|
Fox Chase Cancer Center CCOP-Research Base Program
|
3U10CA101178-03S2
|
$624,917
|
$31,246
|
ENGSTROM, PAUL
|
FOX CHASE CANCER CENTER
|
|
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
|
1R01CA127488-01A1
|
$691,509
|
$691,509
|
MANNE, SHARON
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-46S1
|
$113,159
|
$5,658
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-46S2
|
$171,963
|
$8,598
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-46
|
$8,028,491
|
$401,425
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
$140,652
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
$4,943,916
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-10
|
$537,840
|
$268,920
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$94,815
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
HPV: Biology, Clinical Significance and Epidemiology
|
5P01CA042792-20
|
$2,263,372
|
$1,131,686
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immunosupression-Resistant Gene Modified Donor T Cells
|
5R01CA109381-04
|
$323,970
|
$323,970
|
GEORGES, GEORGE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Organ Transplantation Research for this search: $65,435,562
|